Tuberculosis in a solid-organ transplant recipient: modern-day implications

Ayad Jazrawi; Makoto Jones; Abdallah G Kfoury; Patrick W Fisher; Edward M Gilbert; Feras Bader; David Pombo; Kim E Hanson; Josef Stehlik

doi:10.1016/j.healun.2008.11.005

Tuberculosis in a solid-organ transplant recipient: modern-day implications

J Heart Lung Transplant. 2009 Feb;28(2):191-3. doi: 10.1016/j.healun.2008.11.005.

Authors

Ayad Jazrawi¹, Makoto Jones, Abdallah G Kfoury, Patrick W Fisher, Edward M Gilbert, Feras Bader, David Pombo, Kim E Hanson, Josef Stehlik

Affiliation

¹ UTAH Cardiac Transplant Program, Salt Lake City, Utah, USA.

PMID: 19201346
DOI: 10.1016/j.healun.2008.11.005

Abstract

The clinical presentation and disease course of tuberculosis (TB) in a solid-organ transplant (SOT) recipient may be atypical and the risk of mortality is high. Herein we examine the role of the different tests used in diagnosis of TB and review the specifics of anti-mycobacterial therapy and the public health implications of TB in a SOT recipient.

Publication types

Case Reports

MeSH terms

Anti-Bacterial Agents / therapeutic use
Antitubercular Agents / therapeutic use*
Cardiomyopathies / surgery
Drug Therapy, Combination
Heart Transplantation / adverse effects*
Humans
Male
Postoperative Complications / diagnostic imaging
Postoperative Complications / microbiology*
Tomography, X-Ray Computed
Treatment Outcome
Tuberculosis / diagnosis*
Tuberculosis / diagnostic imaging
Tuberculosis / drug therapy
Young Adult

Substances

Anti-Bacterial Agents
Antitubercular Agents